CYRUSONE INC. Depreciation and Amortization Expense
CYRUSONE INC. reported Depreciation and Amortization Expense of $499.20 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DepreciationAndAmortization · last filed 2022-02-17
- CYRUSONE INC. depreciation, depletion and amortization, nonproduction for the quarter ending 2021-12-31 was $126.60M, a 6.84% increase year-over-year.
- CYRUSONE INC. depreciation, depletion and amortization, nonproduction for the quarter ending 2021-09-30 was $127.50M, a 12.73% increase year-over-year.
- CYRUSONE INC. depreciation, depletion and amortization, nonproduction for the quarter ending 2021-06-30 was $123.70M, a 12.76% increase year-over-year.
- CYRUSONE INC. depreciation, depletion and amortization, nonproduction for the quarter ending 2021-03-31 was $121.40M, a 12.30% increase year-over-year.
- CYRUSONE INC. depreciation, depletion and amortization, nonproduction for fiscal 2021 was $499.20M, a 11.08% increase from fiscal 2020.
- CYRUSONE INC. depreciation, depletion and amortization, nonproduction for fiscal 2020 was $449.40M, a 7.59% increase from fiscal 2019.
- CYRUSONE INC. depreciation, depletion and amortization, nonproduction for fiscal 2019 was $417.70M, a 25.02% increase from fiscal 2018.
- CYRUSONE INC. depreciation, depletion and amortization, nonproduction for fiscal 2018 was $334.10M, a 29.05% increase from fiscal 2017.
| Period end | Depreciation, Depletion and Amortization, Nonproduction 3 month | Depreciation, Depletion and Amortization, Nonproduction 6 month | Depreciation, Depletion and Amortization, Nonproduction 9 month | Depreciation, Depletion and Amortization, Nonproduction 12 month |
|---|---|---|---|---|
| 2021-12-31 | $126.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $254.10M derived: sum of 2 quarters · filed 2022-02-17 | $377.80M derived: sum of 3 quarters · filed 2022-02-17 | $499.20M 10-K · filed 2022-02-17 |
| 2021-09-30 | $127.50M 10-Q · filed 2021-10-28 | $251.20M derived: sum of 2 quarters · filed 2021-10-28 | $372.60M 10-Q · filed 2021-10-28 | $491.10M derived: sum of 4 quarters · filed 2022-02-17 |
| 2021-06-30 | $123.70M 10-Q · filed 2021-07-29 | $245.10M 10-Q · filed 2021-07-29 | $363.60M derived: sum of 3 quarters · filed 2022-02-17 | $476.70M derived: sum of 4 quarters · filed 2022-02-17 |
| 2021-03-31 | $121.40M 10-Q · filed 2021-04-29 | $239.90M derived: sum of 2 quarters · filed 2022-02-17 | $353.00M derived: sum of 3 quarters · filed 2022-02-17 | $462.70M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-12-31 | $118.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $231.60M derived: sum of 2 quarters · filed 2022-02-17 | $341.30M derived: sum of 3 quarters · filed 2022-02-17 | $449.40M 10-K · filed 2022-02-17 |
| 2020-09-30 | $113.10M 10-Q · filed 2021-10-28 | $222.80M derived: sum of 2 quarters · filed 2021-10-28 | $330.90M 10-Q · filed 2021-10-28 | $439.00M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | $109.70M 10-Q · filed 2021-07-29 | $217.80M 10-Q · filed 2021-07-29 | $325.90M derived: sum of 3 quarters · filed 2022-02-17 | $431.30M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $108.10M 10-Q · filed 2021-04-29 | $216.20M derived: sum of 2 quarters · filed 2022-02-17 | $321.60M derived: sum of 3 quarters · filed 2022-02-17 | $423.70M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | $108.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $213.50M derived: sum of 2 quarters · filed 2022-02-17 | $315.60M derived: sum of 3 quarters · filed 2022-02-17 | $417.70M 10-K · filed 2022-02-17 |
| 2019-09-30 | $105.40M 10-Q · filed 2020-10-29 | $207.50M derived: sum of 2 quarters · filed 2020-10-29 | $309.60M 10-Q · filed 2020-10-29 | $407.50M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-06-30 | $102.10M 10-Q · filed 2020-07-31 | $204.20M 10-Q · filed 2020-07-31 | $302.10M derived: sum of 3 quarters · filed 2021-02-19 | $386.10M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-03-31 | $102.10M 10-Q · filed 2020-04-30 | $200.00M derived: sum of 2 quarters · filed 2021-02-19 | $284.00M derived: sum of 3 quarters · filed 2021-02-19 | $361.60M derived: sum of 4 quarters · filed 2021-02-19 |
| 2018-12-31 | $97.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $181.90M derived: sum of 2 quarters · filed 2021-02-19 | $259.50M derived: sum of 3 quarters · filed 2021-02-19 | $334.10M 10-K · filed 2021-02-19 |
| 2018-09-30 | $84.00M 10-Q · filed 2019-10-31 | $161.60M derived: sum of 2 quarters · filed 2019-10-31 | $236.20M 10-Q · filed 2019-10-31 | $307.00M derived: sum of 4 quarters · filed 2020-02-20 |
| 2018-06-30 | $77.60M 10-Q · filed 2019-08-02 | $152.20M 10-Q · filed 2019-08-02 | $223.00M derived: sum of 3 quarters · filed 2020-02-20 | $291.70M derived: sum of 4 quarters · filed 2020-02-20 |
| 2018-03-31 | $74.60M 10-Q · filed 2019-05-02 | $145.40M derived: sum of 2 quarters · filed 2020-02-20 | $214.10M derived: sum of 3 quarters · filed 2020-02-20 | $277.80M derived: sum of 4 quarters · filed 2020-02-20 |
| 2017-12-31 | $70.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $139.50M derived: sum of 2 quarters · filed 2020-02-20 | $203.20M derived: sum of 3 quarters · filed 2020-02-20 | $258.90M 10-K · filed 2020-02-20 |
| 2017-09-30 | $68.70M 10-Q · filed 2018-11-01 | $132.40M derived: sum of 2 quarters · filed 2018-11-01 | $188.10M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $63.70M 10-Q · filed 2018-08-02 | $119.40M 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $55.70M 10-Q · filed 2018-05-03 | |||
| 2016-12-31 | $183.90M 10-K · filed 2019-02-22 | |||
| 2015-12-31 | $141.50M 10-K · filed 2018-02-22 |